Atomistry » Ruthenium » PDB 4l55-5ira » 4rlo
Atomistry »
  Ruthenium »
    PDB 4l55-5ira »
      4rlo »

Ruthenium in PDB 4rlo: Human P70S6K1 with Ruthenium-Based Inhibitor EM5

Enzymatic activity of Human P70S6K1 with Ruthenium-Based Inhibitor EM5

All present enzymatic activity of Human P70S6K1 with Ruthenium-Based Inhibitor EM5:
2.7.11.1;

Protein crystallography data

The structure of Human P70S6K1 with Ruthenium-Based Inhibitor EM5, PDB code: 4rlo was solved by J.F.Domsic, J.Barber-Rotenberg, J.Salami, J.Qin, R.Marmorstein, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 49.03 / 2.53
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 78.515, 62.882, 86.718, 90.00, 94.02, 90.00
R / Rfree (%) 19.2 / 22.2

Other elements in 4rlo:

The structure of Human P70S6K1 with Ruthenium-Based Inhibitor EM5 also contains other interesting chemical elements:

Fluorine (F) 1 atom
Chlorine (Cl) 6 atoms

Ruthenium Binding Sites:

The binding sites of Ruthenium atom in the Human P70S6K1 with Ruthenium-Based Inhibitor EM5 (pdb code 4rlo). This binding sites where shown within 5.0 Angstroms radius around Ruthenium atom.
In total only one binding site of Ruthenium was determined in the Human P70S6K1 with Ruthenium-Based Inhibitor EM5, PDB code: 4rlo:

Ruthenium binding site 1 out of 1 in 4rlo

Go back to Ruthenium Binding Sites List in 4rlo
Ruthenium binding site 1 out of 1 in the Human P70S6K1 with Ruthenium-Based Inhibitor EM5


Mono view


Stereo pair view

A full contact list of Ruthenium with other atoms in the Ru binding site number 1 of Human P70S6K1 with Ruthenium-Based Inhibitor EM5 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ru401

b:61.0
occ:1.00
RU A:3T3401 0.0 61.0 1.0
N12 A:3T3401 1.9 51.7 1.0
N20 A:3T3401 2.0 41.3 1.0
N18 A:3T3401 2.1 53.0 1.0
S13 A:3T3401 2.5 64.0 1.0
S10 A:3T3401 2.5 48.2 1.0
S14 A:3T3401 2.6 73.9 1.0
C21 A:3T3401 2.8 38.6 1.0
C37 A:3T3401 2.8 38.1 1.0
C9 A:3T3401 2.9 58.2 1.0
C36 A:3T3401 3.1 44.1 1.0
C5 A:3T3401 3.2 56.0 1.0
C16 A:3T3401 3.3 56.4 1.0
C15 A:3T3401 3.3 51.7 1.0
C6 A:3T3401 3.3 54.1 1.0
C22 A:3T3401 3.3 40.5 1.0
C11 A:3T3401 3.4 50.3 1.0
C7 A:3T3401 3.5 52.0 1.0
C28 A:3T3401 4.1 39.8 1.0
C23 A:3T3401 4.1 43.3 1.0
C33 A:3T3401 4.2 39.9 1.0
HA3 A:GLY98 4.2 58.6 1.0
C27 A:3T3401 4.4 37.6 1.0
C35 A:3T3401 4.4 47.2 1.0
S8 A:3T3401 4.5 82.8 1.0
HG21 A:VAL105 4.6 55.6 1.0
HB A:VAL105 4.7 56.5 1.0
C34 A:3T3401 4.8 39.0 1.0

Reference:

J.Qin, R.Rajaratnam, L.Feng, J.Salami, J.S.Barber-Rotenberg, J.Domsic, P.Reyes-Uribe, H.Liu, W.Dang, S.L.Berger, J.Villanueva, E.Meggers, R.Marmorstein. Development of Organometallic S6K1 Inhibitors. J.Med.Chem. V. 58 305 2015.
ISSN: ISSN 0022-2623
PubMed: 25356520
DOI: 10.1021/JM5011868
Page generated: Wed Dec 16 02:08:22 2020

Last articles

Zn in 7RRP
Zn in 7OKY
Zn in 7OL0
Zn in 7OKX
Zn in 7ONB
Zn in 7RSF
Zn in 7OUF
Zn in 7OUG
Zn in 7OUH
Zn in 7RGN
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy